Country | Shipping method | Delivery time | Price | |
|
![]() |
14-21 days | 10$ | Tracking# available in 4 days |
![]() |
9-14 days | 30$ | Tracking# available in 2 days |
Daliresp is prescribed to lower the risk of COPD exacerbations in patients with severe chronic obstructive pulmonary disease linked to chronic bronchitis. Roflumilast, the active ingredient, is a phosphodiesterase-4 (PDE4) inhibitor that reduces lung inflammation.
Take Daliresp by mouth once daily, with or without food, as directed by your healthcare provider. Key instructions include:
Important precautions to consider before using Daliresp:
Daliresp should not be used in these situations:
Common side effects of Daliresp may include:
Serious but rare side effects require immediate medical attention:
Daliresp may interact with these medications:
Always disclose all medications and supplements to your doctor before starting Daliresp.
If you miss a Daliresp dose:
Overdose symptoms require emergency care:
Proper storage guidelines for Daliresp:
This medication information provides general guidance only and does not replace professional medical advice. The content does not include all possible uses, precautions, or drug interactions. Never use this information for self-diagnosis or self-treatment without consulting a qualified healthcare provider. The accuracy and completeness of this information cannot be guaranteed. We are not liable for any health outcomes or damages resulting from the use or misuse of this information. Always consult your physician for personalized medical advice.